Genetic Spectrum of Primary Ciliary Dyskinesia in Iranian patients: A Systematic Review Protocol | ||
| Journal of Integrated Maternal and Pediatric Care | ||
| Volume 9, Issue 1, September 2026, Pages 60-66 PDF (569.87 K) | ||
| Document Type: Protocol | ||
| DOI: 10.18502/jimpc.v9i1.22986 | ||
| Authors | ||
| Seyedeh Zalfa Modarresi* 1, 2; Zahra Alizadeh3, 4 | ||
| 1Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran | ||
| 2Department of Pediatrics, Shahid Sadoughi Hospital, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran | ||
| 3Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran | ||
| 4Pediatrics Center of Excellence, Children's Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran | ||
| Abstract | ||
| Background: Primary ciliary dyskinesia (PCD) is a rare inherited disorder caused by defects in the structure or function of motile cilia. More than 60 genes have been linked to PCD, but the genetic variants reported in affected individuals differ across populations. This systematic review aims to describe the genetic spectrum of PCD reported in Iran, examine parental consanguinity, and explore possible relationships between genetic findings and clinical features. Methods: We will search PubMed/MEDLINE, Scopus, Web of Science, Embase, Google Scholar, and Iranian databases, including SID, Magiran, and IranMedex, from inception without date re-strictions. Case reports, case series, and observational studies describing molecular genetic findings in Iranian patients with PCD will be eligible. Data will be collected on patient characteristics, pa-rental consanguinity, diagnostic approaches, affected genes, reported variants, zygosity, and clinical manifestations. Variants will be reviewed using American College of Medical Genetics and Ge-nomics/Association for Molecular Pathology (ACMG/AMP) guidelines. Study quality will be eval-uated using appropriate Joanna Briggs Institute (JBI) tools and the Newcastle–Ottawa Scale (NOS). Results: The review will summarize the genes and variants reported in Iranian patients, highlight recurrent and potential founder variants, describe reported consanguinity patterns, and examine available evidence on genotype–phenotype relationships. When individual patient data are availa-ble, genetic findings will be compared with clinical and demographic characteristics. Conclusion: By bringing together the available evidence, this review will clarify the reported ge-netic landscape of PCD in Iran. The findings may help guide molecular testing, strengthen genetic counseling, and support the development of national PCD registries. | ||
| Keywords | ||
| Primary Ciliary Dyskinesia; Genetic Variation; Ciliopathies; Consanguinity; Iran | ||
| References | ||
|
| ||
|
Statistics Article View: 65 PDF Download: 27 |
||